Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
Florence Bada, Nick Blok, Evaezi Okpokoro, Saswata Dutt, Christopher Akolo, Patrick Dakum, Alash’le Abimiku
PLoS ONE · 2021-10
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0241065.].
MeSH terms
- Rifampicin
- Multi-drug-resistant tuberculosis
- Extensively drug-resistant tuberculosis
- Medicine
- Tuberculosis
- Drug resistance
- Drug
- Tb treatment
- Pharmacology
- Internal medicine
- Intensive care medicine